Mimecan/OIF Antibody [DyLight 650]

Product Discontinued

Mimecan/OIF Antibody [DyLight 650] Summary

• Description: This conjugate is made on demand and is not held in inventory. Each order represents a unique lot. All conjugates are generated using validated conjugation protocols and meet strict degree of labeling (F/P) specifications; additional information is available upon request. The antibody concentration is provided on the individual product label.
  
  For specialized conjugation needs, like large quantities, specific concentrations, and defined F/P ratios, bulk and custom antibody conjugation services are available.
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human Mimecan
  Ala20-Phe298
  Accession # P20774
• Specificity: Detects human Mimecan in direct ELISAs and Western blots. In these formats, approximately 5% cross‑reactivity with recombinant mouse Mimecan is observed.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: OGN
• Purity: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Western Blot
• Application Notes: Recommended applications are based on validated applications from the unconjugated base product AF2660. This conjugated antibody is not kept in inventory and is made to order using validated conjugation protocols.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Antigen Affinity-purified

Notes

DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.

Alternate Names for Mimecan/OIF Antibody [DyLight 650]

• DKFZp586P2421
• KSPG25
• mimecan proteoglycan
• Mimecan
• OGN
• OIF
• OIFOG
• osteoglycin (osteoinductive factor)
• osteoglycin
• Osteoinductive factor
• SLRR3A
• SLRR3Acorneal keratan sulfate proteoglycan

Background

OIF is involved in inducing bone formation with TGGB1 and TGFB2 as well as being an important regulator of left ventricular mass. OIF is thought to have a role in cellular growth regulation. OIF is known to have interactions with CRK, ABL1, SRC, IRF1 and USF1. Studies of OIF have been conducted in relation to cholera, conjunctivitis, interferon, adenoma, pituitary tumor and paratyphoid fever.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: OGN